Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00680589
Recruitment Status : Completed
First Posted : May 20, 2008
Last Update Posted : March 28, 2011
Information provided by:
Memorial Sloan Kettering Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2011
  Study Completion Date : March 2011